Your session is about to expire
← Back to Search
Biofeedback for Improving Walking Speed After Stroke
N/A
Recruiting
Led By Brian A Knarr, PhD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in walking speed from pre-training, immediately after completing the training (post-training), and 24-hour follow-up
Awards & highlights
Study Summary
This trial is testing a wearable device that gives visual feedback to help people with stroke increase their walking speed.
Who is the study for?
This trial is for individuals aged 19-80 who had a stroke at least 6 months ago and can walk 10 meters with or without help. They must be able to understand instructions and communicate well (moderate score on cognitive tests). It's not suitable for those with multiple strokes, cardiorespiratory or musculoskeletal issues affecting walking, visual problems, hemi-neglect, or other neurological disorders.Check my eligibility
What is being tested?
The study is testing a wearable device that gives visual feedback on hip movement during normal walking to see if it helps improve walking speed and gait in people who have had a stroke. Participants' walking abilities will be measured before and after using the device, as well as one day later.See study design
What are the potential side effects?
There may not be significant side effects from using the biofeedback device itself; however, increased physical activity could potentially cause muscle soreness or fatigue.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in walking speed from pre-training, immediately after completing the training (post-training), and 24-hour follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in walking speed from pre-training, immediately after completing the training (post-training), and 24-hour follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Walking Speed
Secondary outcome measures
Peak Hip Extension
Peak Propulsive Force
Step length
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Hip BiofeedbackExperimental Treatment1 Intervention
Training: Participants will complete three training bouts in a session. For these training bouts, participants will be instructed to walk around the perimeter of the 9m x 15m laboratory while wearing the custom gait biofeedback device and visual display glasses. The training bouts will each be 6 minutes in duration with a 5-minute break in between bouts. The biofeedback will be intermittent, with one minute on and one minute off, in order for the individual to not become dependent on the feedback and to promote motor learning. Participants will be told that the device measures the angle their paretic leg is at, and as they move their leg, the line on the screen will move. They will be shown as they move their leg farther back, the line moves up, closer to the target. Participants will not be given specific feedback on what walking strategies to use to increase hip extension angle. If the participant surpasses the target hip extension angle, the target will blink green.
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,696 Total Patients Enrolled
2 Trials studying Stroke
309 Patients Enrolled for Stroke
Brian A Knarr, PhDPrincipal InvestigatorUniversity of Nebraska
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 19 and 80 years old.I can understand instructions and communicate well.I have had more than one stroke.I have heart, lung, or muscle issues that make it hard for me to walk.I have a neurological condition other than stroke.I can walk 10 meters with or without help from a device.I had a stroke more than 6 months ago.I have trouble seeing or ignore one side of my body.
Research Study Groups:
This trial has the following groups:- Group 1: Hip Biofeedback
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this investigation open to new participants?
"According to clinicaltrials.gov, this particular medical research is not seeking participants as of now. The trial was first announced on January 1st 2023 and had its last update on October 31st 2022. Although the study's recruitment has paused, there are 1043 other trials that are currently welcoming patients into their studies."
Answered by AI
Is this trial open to participants of any age, including younger adults?
"The age range for this trial is 19 years and above to 80 years or younger."
Answered by AI
Does this clinical trial offer opportunities for individuals to participate?
"To qualify for this study, applicants must have suffered a stroke and be between 19 and 80 years of age. 38 participants are being sought after in total."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger